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Abstract
Background: Oral malignancies currently constitute the sixth most common malignancy globally. Recent
studies have shown strong correlation between Human Papillomavirus (HPV) and head and neck cancers,
indicating that approximately 50% of oropharangeal cancers in the western world can be attributed to HPV.
Furthermore, the relationship between high risk HPV and head and neck squamous cell carcinoma
(HNSCC) is strengthened by an approximately 14 fold increase in risk for individuals who are infected with
HPV 16.4 Yet the implementation of a well-studied, effective clinical screening tool in the detection of oral
HPV has not been established. The purpose of this systematic review is to investigate different screening
methods for detection and typing of oral HPV and to establish the need for a large randomized control study
to create new guidelines by which HPV screening can be initiated.
Methods: An exhaustive literature search was performed using MEDLINE, CINAHL, and Web of Science
databases using the following search terms “human papillomavirus” or “human papillomaviruses,” combined
with “oral mucosa” or “oral malignancies” limited to publications in English performed on humans. Excluded
were studies that focused on HIV positive or immunocompromised patients, studies that focused on DNA
processing, systematic reviews. There were no exclusions made by GRADE criteria.
Results: The two studies presented in this systematic review have showed that mouth rinse and superficial
scrapings are more effective than biopsies in the harvesting of oral DNA and in the detection of HPV in the
oral cavity.
Conclusion: Repeated, definitive, single protocol studies have yet to determine which technique is most
accurate for the harvesting of oral DNA in the detection of HPV, but all studies presented in this systematic
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Background: Oral malignancies currently constitute the sixth most common malignancy 
globally. Recent studies have shown strong correlation between Human Papillomavirus 
(HPV) and head and neck cancers, indicating that approximately 50% of oropharangeal 
cancers in the western world can be attributed to HPV. Furthermore, the relationship 
between high risk HPV and head and neck squamous cell carcinoma (HNSCC) is 
strengthened by an approximately 14 fold increase in risk for individuals who are 
infected with HPV 16.4 Yet the implementation of a well-studied, effective clinical 
screening tool in the detection of oral HPV has not been established. The purpose of this 
systematic review is to investigate different screening methods for detection and typing 
of oral HPV and to establish the need for a large randomized control study to create new 
guidelines by which HPV screening can be initiated. 
Methods: An exhaustive literature search was performed using MEDLINE, CINAHL, 
and Web of Science databases using the following search terms “human papillomavirus” 
or “human papillomaviruses,” combined with “oral mucosa” or “oral malignancies” 
limited to publications in English performed on humans. Excluded were studies that 
focused on HIV positive or immunocompromised patients, studies that focused on DNA 
processing, systematic reviews. There were no exclusions made by GRADE criteria.  
Results: The two studies presented in this systematic review have showed that mouth 
rinse and superficial scrapings are more effective than biopsies in the harvesting of oral 
DNA and in the detection of HPV in the oral cavity.   
Conclusion: Repeated, definitive, single protocol studies have yet to determine which 
technique is most accurate for the harvesting of oral DNA in the detection of HPV, but all 
studies presented in this systematic review showed that mouth rinse and superficial oral 
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The Effective Clinical Detection of Oral HPV in the Prevention of HPV 
Related Head and Neck Malignancies 
 
BACKGROUND 
 Currently, oral malignancies constitute the sixth most common 
malignancy globally.1 More than 90% of these malignancies are found to be squamous 
cell carcinoma (SCC).1 Recent studies have shown strong correlation between Human 
Papillomavirus (HPV) and head and neck cancers, indicating that approximately 50% of 
oropharangeal cancers in the western world can be attributed to HPV30-32. The Center for 
Disease Control (CDC) reports that every year in the United States 1500 women and 
5600 men get HPV-associated oropharyngeal cancers (cancers of the back of throat 
including base of tongue and tonsils), the majority of which are squamous cell 
carcinoma.35 
HPV belongs to the Papillomaviridae family, small non-enveloped DNA virus that 
are known collectively as papillomaviruses. Several hundred genotypes have been 
recognized differing slightly in their DNA sequence in specific genomic regions.10 
Papillomaviruses have been found to exclusively infect epithelial cells primarily in 
humans, with each genotype affecting a different epithelial surface that can either be 
mucosal or cutaneous.11 For example HPV 1 will primarily affect the soles of the feet 
while HPV 2 will affect the palms of the hands and the soles of the feet. The superficial 
cutaneous types of HPV that are commonly found to be associated with squamous cell 
carcinoma of the skin are HPV 5 and 8.12,13 Mucosal types of HPV are subdivided into 
two categories, low-risk and high-risk in relation to the potential oncogenic properties of 
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the genotype. The most common low risk types have been shown to be HPV 6 and 11 
which are responsible for many mucosal benign lesions. The most common carcinogenic 
types of HPV include, HPV 16, 18, 31,33,and 45 which have been primarily found in 
squamous cell carcinoma of the cervix, anogenital malignancies, and head and neck 
carcinoma.14-17 These same high-risk strains of HPV have been targeted in recent 
vaccines that have been approved by the Food and Drug Administration (FDA).  
 
Human papillomavirus infection is the most commonly diagnosed sexually 
transmitted disease in the United States.33 Risk increases with multiple sexual partners, 
and individuals with a compromised immune system. It has been found to be associated 
with condyloma acuminatum, squamous intraepithelial lesions and anogenital 
malignancy including cervical, vaginal, vulval, penile, and anal carcinoma. The majority 
(75-80%) of sexually active individuals will acquire a genital tract HPV infection at some 
point in their lives.34 Most of the physical manifestations are found in cutaneous warts 
(hand and plantar), although a percentage of young adults will acquire mucosal types by 
sexual contact.9 Consequently, the majority of HPV infections go unnoticed and the 
infected individual has no indication that there has been a viral invasion.  Like most viral 
infections, a healthy immune system will suppress the HPV virus. Fortunately, 80% of all 
HPV infections will spontaneously resolve.9 More research is needed to determine why 
some HPV viruses will spontaneously resolve and why some progress to cervical cancers 
and HNSCC.  
The correlation between HPV and cervical cancer has become widely accepted, 
not only in the medical community but in the general population. Therefore standardized 
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screening guidelines have been established for the effective detection of HPV of the 
cervix with high detection rates of cervical cell dysplasia. The CDC reports each year, 
about 12 000 women get cervical cancer in the U.S.35  High-risk HPV types have been 
identified as a significant risk factor for cervical cancer. HPV is detected in 95-100% of 
invasive cervical cancers.23 The FDA has approved testing for high-risk HPV DNA in 
conjunction with Pap smears for routine cervical screening of women aged 30 years and 
older. A negative HPV DNA test increases assurance that there is very little risk of a 
serious abnormality developing over the next several years. The US Preventative 
Services Taskforce reports that cervical cancer rates in the United States have decreased 
from 14.2 new cases per 100 000 women in 1973 to 3.0 cases per 100 000 women in 
1998.28 Despite the falling incidence, cervical cancer remains the tenth leading cause of 
cancer death.28 
Given the presence of HPV is necessary for the development of most cervical 
cancer, it is likely that it is important in the oral cavity as well. This association is 
strengthened by the fact that it is the same HPV oncogenes (16, 18, 31, 33 and 45) that 
cause cervical carcinoma which are found to cause the majority of malignancies in the 
oral cavity.2 HPV 16 has been identified as the most common type that has been found in 
HNSCC, representing >95% of all HPV positive SCC.3 Other high-risk HPV types 
(18,31,33, and 45) represent the remaining 5%-10%. Furthermore, the relationship 
between high risk HPV and head and neck squamous cell carcinoma (HNSCC) is 
strengthened by an approximately 14 fold increase in risk for individuals who are 
infected with HPV 16.4  
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In the past, health professionals and researchers have believed the etiology of SCC to 
be primarily due to exposure to tobacco and alcohol. This carcinogenic exposure 
currently accounts for a 4-6 fold increase in the prevalence of oral SCC. (10) However, as 
the rates of smoking continue to decline in the United States, the rates of oropharyngeal 
cancer have risen 3% annually from the years 1997-20035 especially in young men, non-
smokers and non-drinkers.25-27 This evidence shows that these risk factors may be 
independent of each other. It has been reported that 15-20% of all individuals who have 
HNSCC have never, or rarely been exposed to these carcinogens.6,7 With this changing 
demographic there is less specific relevant data to guide clinicians in making a diagnosis 
of HNSCC. In the past, a clinical history of chewing or smoking tobacco or heavy 
drinking would be an indication for concern regarding oral cancer. Oral HPV commonly 
presents without physical symptoms; as a result, clinical diagnosis is very difficult to 
make. Currently, clinicians are without guidelines to determine which patients need to be 
screened for HNSCC and early detection is vital to determining the mortality of these 
individuals.  
Head and neck carcinomas are associated with significant morbidity and disfiguration 
which makes early detection of oncogenic viruses of great importance. A recent meta 
analysis8 found that there is a better prognosis for those who have HNSCC associated 
with HPV as opposed to HPV negative cancers.  Knowing the better prognosis for these 
patients, oncologists are more recently implementing surgical treatment and observation 
only for patients with HPV positive HNSCC. Oncologists are taking into consideration 
the younger demographic that this disease is affecting and deciding that the side effects of 
radiation and chemotherapy create greater long-term health implications than the disease 
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itself. Patients with HPV positive tumors respond well to radiation and chemotherapy 
ultimately leading to lower risk of mortality (meta HR, 0.85; 95% CI, 0.7-1.0) and 
decreased recurrence rates (meta HR, 0.62; 95%CI, 0.5-0.8).8   
Interestingly, HPV 16 is responsible for 28% of oral HPV infections while 
oropharangeal cancers caused by HPV 16  is approximately >95%.3  A recent study 
reported HPV16 accounts for approximately 25% of cervical infections among 
cytologically normal women.18 Furthermore, cervical cancers associated with HPV 16 are 
approximately 50%.21 This data suggests that HPV 16 in the oral cavity has a greater 
potential to turn malignant when compared to cervical cells.  
 Within the past twenty years there has been an unmistakable reduction in cervical 
cancer incidence, and mortality due to screening guidelines and treatment protocols. HPV 
should be considered a biomarker for head and neck squamous cell carcinoma, and it is 
clear that malignancies of the oral cavity would benefit equally from a similar course of 
action.   
Purpose 
The purpose of this systematic review is to investigate different screening methods 
for detection and typing of oral HPV, and to establish the need for a large randomized 
control study to create new guidelines by which HPV screening can be initiated. 
Clinical Question 
 The clinical question that this systematic review would like to address is whether 
or not there is a Gold Standard screening method established in the detection of HPV in 





An exhaustive literature search was performed using MEDLINE, CINAHL, and 
Web of Science databases using the following search terms “human papillomavirus” or 
“human papillomaviruses,” combined with “oral mucosa” or “oral malignancies” limited 
to publications in English performed on humans. Excluded were studies that focused on 
HIV positive or immunocompromised patients, studies that focused on DNA processing, 
systematic reviews. There were no exclusions made by GRADE criteria.  
RESULTS 
 Results of the online search brought forth 103 possible journal articles. After 
reviewing the titles and abstracts of these articles, 15 were identified that appeared to 
assess the comparison of different cell harvesting techniques in the oral mucosa and the 
detection of HPV.  After further review, two studies remained and are evaluated in this 
systematic review. A summary of these studies can be found in Table 1.  
Lawton et al  
Lawton et al29 explained that no studies had previously addressed the 
establishment of a standardized method for the harvesting of oral mucosal cells, therefore 
the purpose of this study was to compare three different methods for cell collection 
(mouth rinse, biopsy and superficial scrapings). 29 
All 60 participants who enrolled in the study29 volunteered form the dental school 
at the University of Queensland, Australia. The participants were consenting adults 
attending dental extractions that had otherwise had normal oral mucosa with no 
complaints of oral lesions or leukoplakia.29 
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 Specimen Collection- One investigator performed all of the specimen collection. 
Specimens were collected by standardized method using a sterilized spoon shaped spatula 
and each mucosal site was scraped three times. The total number of scrapings collected 
were 53. Care was taken to avoid cross contamination. The specimen was placed in a 
transport medium and incubated at 37 degrees Celsius overnight.  Biopsies were taken 
from the full thickness of the buccal mucosa and placed in the transport medium and 
stored at 37degrees Celsius overnight. The total number of biopsies collected was 59. 
Participants were then asked to return for a follow up appointment to collect the mouth 
rinse samples. Of the total participants, 49 subjects returned and were asked to rinse 10ml 
of 3% sucrose solution for 30 seconds. These samples were subject to centrifuge for 10 
min at 2000rpm and placed in the same transport medium and stored at 37degrees 
Celsius. 29   
DNA Extraction- DNA was purified by sequential phenol/chloroform extraction 
and salt/ethanol precipitation using automated 340A Nucleic Acid Extractor (Applied 
Biosystems Inc, Foster City, CA). HPV DNA amplification products were detected by 
dot/blot hybridization. 29  
Results- The average DNA yield from the specimens concluded that the 
mouthwashes produced more DNA (median 15.5ug; range 1.0-149.8) than the biopsies 
taken (median 8.0ug; range 0.8 – 74.3) or superficial scrapings (median 3.1ug; range 0 – 
74.3). This information is represented in Figure 1.  There were 49 subjects that provided 
adequate mouthwash samples and 25 (51%) were shown to be HPV DNA positive by this 
technique.  Fifty three subjects provided samples of oral superficial scrapings of these 
samples 24 (45%) were shown to be HPV DNA positive. Finally, of the biopsies only 7 
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(12%) were positive for HPV. HPV was significantly less likely to be detected using a 
biopsy when compared to each of the other two techniques (p<0.001). This information is 
represented in Figure 2. 29 
Furrer et al  
Furrer et al24 focused on the specificity and sensitivity of biopsies, superficial 
scrapings, and physician’s clinical presumption in the detection of oral HPV. The 
intention of their study was to identify clinical features of HPV infection in the oral 
mucosa in potentially malignant and malignant lesions, in order to assist the clinician in 
the diagnosis of potentially malignant lesions that could evolve into HNSCC or verucous 
carcinoma (VC). 24 
Biopsies and cytological scrapings were collected from 59 consenting adults. The 
case participants included 33 patients with oral lesions that were either potentially 
malignant or malignant lesions. All potentially malignant lesions were considered, 
leukoplakias, plaques as well as atrophic lichen planus. Malignant lesions included 
previously diagnosed oropharangeal squamous cell carcinoma and verucus carcinoma.   
The patients, before being selected for the case group were diagnosed clinically and by 
histopathology. The control group included 23 patients that had clinically normal oral 
mucosa. Clinical diagnosis of oral HPV infection was considered if the patient presented 
with bright, white, flat lesions, that showed slightly elevated plaques or patches with an 
erithematous base.24 
Specimen Collection- Samples were collected in the oral mucosa and contra 
lateral mucosa by a sterile metallic spatula. Each site was scraped five times and caution 
was taken to not cross contaminate between sites. Individual samples were analyzed 
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using the PCR-Southern Blot genotyping for cytological diagnosis. Each sample was 
stored in a transport medium at -80 degrees Celsius. 24 
 Keeping in mind the stated purpose of the study24 was to evaluate the 
effectiveness of non-invasive sampling techniques, biopsies were only taken from 
patients with suspected malignant and malignant lesions. Each biopsy sample was taken 
from the clinically suspicious tissue of the oral mucosa, taking the full extension of the 
lesion. Biopsy samples were analyzed by PCR-Southern blot genotyping and also 
histopathological examination. 24  
Results-  Biopsies from nine patients (41%) with potentially malignant and 
malignant lesions were HPV positive by PCR-Southern blot analysis in the biopsy tissue. 
On the other hand, 21 (95%) and 22 (100%) of these lesions were HPV positive when 
superficial scrapes of the lesion's mucosa and the contralateral normal mucosa were, 
respectively, analyzed.  There was no significant difference in HPV detection between 
lesion and contralateral normal mucosa scrapes (McNemar, P = 0.3938), but there was a 
significant difference between biopsies and superficial scrapes either from the lesion or 
the contralateral normal mucosa (McNemar, P < 0.0001). It is important to point out that 
β globin gene was normally amplified from all negative biopsy samples. Biopsy DNA 
(median 14 ng) was between four and 2000 times higher than scraping DNA (median 
0.27 ng). In addition, the sensitivity of the PCR–Southern blot assay established for Hela 
cells was around 0.155 pg of Hela DNA. Hence, the lower HPV detection in biopsy 
tissues was not due to insufficient amount of DNA. 24 
Of the potentially malignant and malignant lesions that were identified by 
clinical criteria, 67% were found to be HPV positive by either cytopathology or 
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histopathology. There were significant differences between cytology results and the 
clinical presumption results and the histopathological results. 24  
Of the 23 control subjects, 91.3% were HPV negative, 4.3% were HPV 18 
positive and 4.3% were HPV positive for other genotypes. Of the 18 subjects with 
previously confirmed oral malignancy, all were HPV positive with the largest 
representation of the infections being HPV 16 strain (39%).24 
DISCUSSION 
The two studies presented in this systematic review have shown that mouth rinse 
and superficial scrapings are more effective than biopsies in the harvesting of oral DNA 
and in the detection of HPV in the oral cavity.24,29  Furrer et al24 concluded that the ability 
to detect HPV DNA in the oral mucosa is much more likely by superficial scrapings than 
biopsies. These findings are in agreement with Lawton et al29 who further concluded that 
oral mouth rinse is superior to biopsies and superficial scrapings in HPV detection in the 
oral cavity.  
These results are in agreement with findings in a study performed by Syrjanen 
and Syrjanen on 102 cervical biopsies know to contain HPV. This study demonstrated 
that the presence of HPV was much more superficial than once believed. Showing that 
HPV in the epithelial layers increased progressively from the basal layer (5.8%) to the 
superficial layers (100%). This is the reason that pap testing is done with a cytological 
brushing of cervical mucosa and not biopsies.  
 In order to assess the quality of research GRADE criteria were used. Both  
studies initially received a moderate grade for being observational studies at their 
beginning and not randomized control trials. A point in both studies was subtracted due 
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to the process not being blinded. Another point was taken off for inconsistent results. One 
more point was subtracted from each study due to small sample size and lack of 
precision. This warrants a very low quality of evidence for recommendation for this 
specific intervention. According to the GRADE criteria, very low-grade means “signifies 
the effect is uncertain.”  Future studies would have to be large randomized studies that 
are assessing one universal screening procedure to show a true benefit of this screening 
tool. 
Validity 
The lack of randomized control trial in the studies reviewed resulted in 
compromised validity. GRADE assessment performed on both studies24,29 determined, 
due to a total sample size is being lower than optimal, there was significant lack of 
precision. In turn this made it difficult to determine if the results would be reproducible in 
a clinical setting. 
Limitations of the Study 
  Of the presented studies, limitations included the lack of large multi-centered 
randomized control trial, which would have given a larger sample size, and a more 
diverse population and reduce the risk of bias.  
 There were variances in the way that each study analyzed the collected sample of 
DNA. Lawton et al29 used a Dot/Blot hybridization that uses a specific standardized 
protocol for DNA amplification whereas Furrer et al24 used a Southern Blot hybridization 
that implements an entirely different method. One universal DNA analysis technique will 
reduce the variability of results.  DNA amplification techniques have been studied to a 
large extent in the detection of cervical HPV and the prevention of cervical cancer.  
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Unfortunately, there has yet to be a well-established gold standard for the analysis 
of oral HPV. Without a well-studied gold standard for testing it makes the introduction 
and comparison of new testing modalities difficult.   
Recommendations- 
It is clear that more information is needed to make clinical recommendations that 
would be accepted in the medical community, but this is one step in the determination of 
these recommendations.  A large multicentre randomized control study is essential in the 
development of these guidelines.  This can be accomplished simply due to the fact that 
the population that is being studied is the general population, and this would be an easily 
administered mouthwash collection that is cheap, and non-invasive.  
CONCLUSION 
The studies presented show that the harvesting of oral mucosa from biopsies are 
less accurate in detecting the HPV virus when compared to superficial scrapings and 
mouthwashes.  A simple oral mouth rinse given in the office to collect DNA samples 
would be an easily administered, inexpensive, non-invasive screening method for oral 
HPV detection for individuals who present with oral leukoplakia, potentially malignant 
lesions or have concerns regarding oral health. Furthermore, with this information 
clinicians and researchers will be able to track individuals who have a known high-risk 
oral HPV infection and collect data on progression of oral HPV to HNSCC. Although 
more information is needed to make clinical guidelines for oral HPV screening, there is a 
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Table 1 : GRADE Assessment 
 
Quality assessment No of patients Results 
Quality  
 Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Case  Control   





risk of bias 
no serious 
inconsistency 
no areas of 
indirectness 




Lawton et al : Human Papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. 
 Observational  no serious 
risk of bias1 
no serious 
inconsistency 
no areas of 
indirectness 
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